Medical Innovation Exchange

FDA Announces Funding Opportunities for Medical Device Development Tools



The FDA Center for Devices and Radiological Health (CDRH) has announced new funding opportunities to support small businesses in developing innovative medical device development tools (MDDTs). The MDDT program was created in collaboration with the National Institutes of Health’s (NIH’s) National Institute of Drug Abuse (NIDA), National Institute of Dental Craniofacial Research (NIDCR) and National Cancer Institute (NCI) as a way for the FDA to qualify tools that medical device sponsors can use in the development and evaluation of medical devices.

It is used to facilitate regulatory decision making by supporting a safety, effectiveness or performance assessment of a medical device in a regulatory submission. Eligible small businesses are defined by the FDA as a business, including its affiliates, whose gross receipts and sales are less than $100 million for the most recent tax year.

Following are current funding opportunities closing in November 2022.

NIH/National Cancer Institute (available for small businesses through November 4, 2022.)

Software to Evaluate Artificial Intelligence/Machine Learning Medical Devices in Oncology Settings

NIH/National Institute of Dental Craniofacial Research (available for small businesses through November 9, 2022.)

Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials

NIH/National Institute of Drug Abuse (available for small businesses through November 14, 2022.)

Novel Drug (DDT) and Medical Device Development Tools (MDDT) for New Therapies for Substance Use Disorders (SUD)

Related Articles

  • FDA

    The document clarifies the MDR regulation and reporting requirements for medical device companies.

  • FDA

    In many cases, establishments are removed due to a failure to renew annual registration with the agency.

  • 3M adhesives

    Selecting the best adhesive is critical.

  • FDA

    Innovators will also receive guidance in the areas of prototyping, engineering, IP, testing, grant-writing and clinical trial design.


Original post:

Post publish date:


Leave a Comment

Your email address will not be published.

Leave the field below empty!